OPK - OPKO HEALTH, INC.

QQQ $ 626.44 $ -5.60 (-0.89 %)

DIA $ 475.08 $ 0.93 (0.2 %)

SPY $ 680.21 $ -3.63 (-0.53 %)

TLT $ 90.57 $ 0.17 (0.19 %)

GLD $ 369.97 $ 4.88 (1.34 %)

Previous Close

$ 1.43

Open

$ 1.42

Bid

$ 1.46 x 3,166

Ask

$ 1.47 x 971

Day's Range

$ 1.43 - $ 1.50

52 Week Range

$ 1.11 - $ 2.04

Volume

2,541,885

Average Volume

Market Cap

1.1B

Beta (5Y Monthly)

$ 0.98

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	10-29-2025	09-30-2025	10-Q
2	07-31-2025	06-30-2025	10-Q
3	05-01-2025	03-31-2025	10-Q
4	03-03-2025	01-01-1970	10-K
5	11-07-2024	09-30-2024	10-Q
6	08-07-2024	06-30-2024	10-Q
7	05-07-2024	03-31-2024	10-Q
8	03-01-2024	12-31-2023	10-K
9	11-06-2023	09-30-2023	10-Q
10	08-03-2023	06-30-2023	10-Q
11	05-03-2023	03-31-2023	10-Q
12	02-27-2023	12-31-2022	10-K
13	11-08-2022	09-30-2022	10-Q
14	08-04-2022	06-30-2022	10-Q
15	05-09-2022	03-31-2022	10-Q
16	03-01-2022	12-31-2021	10-K
17	10-28-2021	09-30-2021	10-Q
18	07-29-2021	06-30-2021	10-Q
19	04-28-2021	03-31-2021	10-Q
20	02-18-2021	12-31-2020	10-K
21	10-29-2020	09-30-2020	10-Q
22	07-31-2020	06-30-2020	10-Q
23	05-06-2020	03-31-2020	10-Q
24	03-02-2020	12-31-2019	10-K
25	11-05-2019	09-30-2019	10-Q
26	08-07-2019	06-30-2019	10-Q
27	05-08-2019	03-31-2019	10-Q
28	03-01-2019	12-31-2018	10-K
29	11-09-2018	09-30-2018	10-Q
30	08-07-2018	06-30-2018	10-Q
31	05-08-2018	03-31-2018	10-Q
32	03-01-2018	12-31-2017	10-K
33	11-08-2017	09-30-2017	10-Q
34	08-08-2017	06-30-2017	10-Q
35	05-10-2017	03-31-2017	10-Q
36	03-01-2017	12-31-2016	10-K
37	11-07-2016	09-30-2016	10-Q
38	08-08-2016	06-30-2016	10-Q
39	05-09-2016	03-31-2016	10-Q
40	02-29-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Barrington Research Maintains Outperform o...
10/30/2025 11:43:25

Barrington Research analyst Michael Petusky maintains OPKO Health (NASDAQ:OPK) with a Outperform and maintains $2.25 price t...

OPKO Health Q3 2025 Adj. EPS $(0.10) Misse...
10/29/2025 20:09:45

ModeX Therapeutics Enters License, Collabo...
10/29/2025 12:02:41

ModeX Therapeutics Inc., an OPKO Health company (NASDAQ: OPK), today announced that it has entered into a license and collabora...

Earnings Scheduled For October 29, 2025
10/29/2025 11:11:56

An OPKO Health's Modex Therapeutics Compan...
10/28/2025 12:08:26

First patient dosed in Phase 1/2a study with novel immune rejuvenator, a trispecific antibody-fusion protein Two MDX2004 abstra...

12 Health Care Stocks Moving In Thursday's...
07/31/2025 21:07:05

OPKO Health Q2 Adj. EPS $(0.07) Beats $(0....
07/31/2025 20:11:07

OPKO Health (NASDAQ:OPK) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.11) by...

Earnings Scheduled For July 31, 2025
07/31/2025 08:32:50

OPKO Health And Entera Bio To Present Abst...
07/08/2025 12:09:42

NextPlat Interim CEO Issues Shareholder L...
06/30/2025 12:08:30

NextPlat Corp (NASDAQ:NXPL, NXPLW)), NXPLW) ("NextPlat" or the "Company"), a global consumer products and servi...

OPKO Health And Entera Bio Say New Pharmac...
06/25/2025 12:12:35

OPKO Health, Inc. (NASDAQ:OPK) and Entera Bio Ltd. (NASDAQ:ENTX) ("Entera") today announced that new pharmacologic and ...

OPKO Health's ModeX Therapeutics Forms Sci...
06/09/2025 12:39:36

Will provide expertise across ModeX's portfolio of next generation multispecific antibodies for complex diseases involving ...

Barrington Research Maintains Outperform o...
05/01/2025 18:20:21

Barrington Research analyst Michael Petusky maintains OPKO Health (NASDAQ:OPK) with a Outperform and maintains $2.25 price t...

OPKO Health Q1 EPS $(0.10) Misses $(0.07) ...
04/30/2025 20:20:01

OPKO Health (NASDAQ:OPK) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.07) ...

Earnings Scheduled For April 30, 2025
04/30/2025 08:32:41

Analyst Expectations For OPKO Health's Future
04/25/2025 19:00:18

This Rocket Lab Analyst Begins Coverage On...
04/25/2025 13:56:22

JP Morgan Initiates Coverage On OPKO Healt...
04/25/2025 10:41:33

JP Morgan analyst Eric Joseph initiates coverage on OPKO Health (NASDAQ:OPK) with a Neutral rating.

OPKO Health Stock: A Deep Dive Into Analys...
04/07/2025 18:00:48

HC Wainwright & Co. Reiterates Buy on OPKO...
04/07/2025 16:57:02

HC Wainwright & Co. analyst Yi Chen reiterates OPKO Health (NASDAQ:OPK) with a Buy and maintains $3 price target.